CVE-2026-32979: high-severity vulnerability in OpenClaw
OpenClaw < 2026.3.11 - Unbound Interpreter and Runtime Commands Bypass in node-host Approval
Published · Updated
21Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 7epss 0.2%
exploitation probability
0.2%top 93% of all CVEs
observed exploitation
nono source reports it
OpenClaw before 2026.3.11 contains an approval integrity vulnerability allowing attackers to execute rewritten local code by modifying scripts between approval and execution when exact file binding cannot occur. Remote attackers can change approved local scripts before execution to achieve unintended code execution as the OpenClaw runtime user.
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N
Affected products
OpenClaw · OpenClawRelated CVEs — OpenClaw
In the same product, most dangerous first.
CVE-2026-25253HIGHCVE-2026-25253EPSS 24.4%CVE-2026-32917CRITICALOpenClaw < 2026.3.13 - Remote Command Injection via Unsanitized iMessage Attachment Paths in SCPEPSS 3.2%CVE-2026-53822HIGHOpenClaw < 2026.5.18 - Command Argument Modification via Shell Wrapper Between Approval and ExecutionEPSS 2.0%CVE-2026-32052MEDIUMOpenClaw < 2026.2.24 - Hidden Command Execution via Shell-Wrapper Positional argv CarriersEPSS 1.6%CVE-2026-44998LOWOpenClaw < 2026.4.20 - Tool Policy Bypass via Bundled MCP/LSP ToolsEPSS 1.2%CVE-2026-44109CRITICALOpenClaw < 2026.4.15 - Authentication Bypass in Feishu Webhook and Card-Action ValidationEPSS 1.1%